Re: 47 Taken out by Gilead for $4.9 billion
in response to
by
posted on
Mar 05, 2020 07:25AM
What I find truly stunning about the purchase of FTSV is that on October 23 2019, its share price was only $5.53, giving it a market cap of about US$300 million. It is being bought out for $95.5 cash at $4.5 billion.
Now FTSV is in cancer research. We are in CVD of course. Not apples to apples...but surely, someone can give us $2 billion in cash?
Icon